Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Journal

Cancer immunology, immunotherapy : CII
ISSN: 1432-0851
Titre abrégé: Cancer Immunol Immunother
Pays: Germany
ID NLM: 8605732

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 29 3 2019
medline: 29 3 2019
entrez: 29 3 2019
Statut: ppublish

Résumé

In the original publication of the article the following abstract and keywords were inadvertently omitted.

Identifiants

DOI: 10.1007/s00262-019-02328-6 PMID: 30919028 PMC: PMC6828222
pubmed: 30919028
doi: 10.1007/s00262-019-02328-6
pii: 10.1007/s00262-019-02328-6
pmc: PMC6828222
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

1037

Commentaires et corrections

Type : ErratumFor

Auteurs

Bas D Koster (BD)

Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
ORCID: 0000-0002-3889-5132

Saskia J A M Santegoets (SJAM)

Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Department of Medical Oncology, Leiden University Medical Center, Hippocratespad 21, 2333 ZD, Leiden, The Netherlands.
ORCID: 0000-0002-2874-4402

Jorien Harting (J)

Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Arnold Baars (A)

Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

S Marieke van Ham (SM)

Departments of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Department of Immunopathology, Landsteiner Laboratory, Amsterdam UMC and Swammerdam Institute for Life Sciences, Sanquin Research, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Rik J Scheper (RJ)

Departments of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Erik Hooijberg (E)

Departments of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Department of Pathology, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
ORCID: 0000-0002-4482-2191

Tanja D de Gruijl (TD)

Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
ORCID: 0000-0003-1464-8978

Alfons J M van den Eertwegh (AJM)

Departments of Medical Oncology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. vandeneertwegh@vumc.nl.
ORCID: 0000-0003-2196-1233

Classifications MeSH